ProAxsis Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:ProAxsis Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011356
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases in complex biological samples with a high level of specificity and selectivity. Its active neutrophil elastase immunoassay is also used to predict future risk of aggravation in bronchiectasis. ProAxsis also provide biomarker services, clinical trial and pharma services, and academic support services. The company specializes in peptide-based inhibitor design and synthesis, activity-based steady state assays, ELISAs and enzyme kinetics and compound characterization, among others. ProAxsis is headquartered in Belfast, the UK.

ProAxsis Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ProAxsis Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ProAxsis Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ProAxsis Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ProAxsis Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
ProAxsis Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ProAxsis Ltd, Medical Equipment, Deal Details 10
Partnerships 10
ProAxsis Enters into Licensing Agreement with Queen’s University 10
ProAxsis Enters into Agreement with US Biotechnology Company 11
Acquisition 12
NetScientific Acquires Majority Stake in ProAxsis 12
ProAxsis Ltd – Key Competitors 13
ProAxsis Ltd – Key Employees 14
ProAxsis Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Corporate Communications 16
Apr 20, 2016: ProAxsis appoints experienced Sales and Marketing Manager 16
Mar 30, 2016: ProAxsis Appoints World-Renowned Respiratory Experts for New Scientific Advisory Board 17
Jan 20, 2016: Renowned protease expert confirmed as CSO of ProAxsis 19
Product News 20
Sep 06, 2017: ProAxsis abstracts at 2017 European Respiratory Society Conference 20
May 05, 2017: ProAxsis abstracts at 2017 American Thoracic Society Conference 21
Other Significant Developments 22
Nov 21, 2017: ProAxsis provides update on commercialisation progress 22
Oct 27, 2017: ProAxsis to test ProteaseTag Technology in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease at National Jewish Health 23
Sep 11, 2017: ProAxsis signs partnership with a large US based biotechnology company 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
ProAxsis Ltd, Medical Equipment, Key Facts, 2016 2
ProAxsis Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
ProAxsis Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ProAxsis Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ProAxsis Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ProAxsis Ltd, Deals By Market, 2011 to YTD 2017 8
ProAxsis Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ProAxsis Enters into Licensing Agreement with Queen’s University 10
ProAxsis Enters into Agreement with US Biotechnology Company 11
NetScientific Acquires Majority Stake in ProAxsis 12
ProAxsis Ltd, Key Competitors 13
ProAxsis Ltd, Key Employees 14
ProAxsis Ltd, Subsidiaries 15

★海外企業調査レポート[ProAxsis Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Invenra Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Invenra Inc (Invenra) is a biotechnology company that discovers and develops multispecific antibodies for immuno-oncology. The company’s pipeline products include t-cell redirecting b-bodies, OX40 agonist, treg depleter SNIPER and exelixis B-Body. Its B-Body and SNIPER technologies are used …
  • L3 Technologies Inc (LLL):企業の戦略的SWOT分析
    L3 Technologies Inc (LLL) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mizuho Trust & Banking Co Ltd:企業の戦略・SWOT・財務情報
    Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Guangzhou Boji Medical & Biotechnological Co Ltd (300404):製薬・医療:M&Aディール及び事業提携情報
    Summary Guangzhou Boji Medical & Biotechnological Co Ltd (BOJI) is a contract research organization. The organization provides services including regulatory affairs, preclinical research, clinical trials I-IV, PMS, clinical trial for medical devices, post marketing studies (PMS), data management and …
  • Pearl Global Industries Limited:企業の戦略・SWOT・財務情報
    Pearl Global Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Pearl Global Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Petromin Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Petromin Resources Ltd (Petromin) is an oil and gas exploration and production company that acquires, explores, develops and produces petroleum and natural gas. The company’s projects include Gilby, Redwater, Frog Lake and MorningSide projects in Alberta, Canada. It also explores and develop …
  • Aker Solutions ASA (AKSO):企業の財務・戦略的SWOT分析
    Aker Solutions ASA (AKSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Straco Corporation Limited:企業の戦略・SWOT・財務情報
    Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Rio Tinto:戦略・SWOT・企業財務分析
    Rio Tinto - Strategy, SWOT and Corporate Finance Report Summary Rio Tinto - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Southern Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Southern Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • CIC Private Banking:企業の戦略・SWOT・財務情報
    CIC Private Banking - Strategy, SWOT and Corporate Finance Report Summary CIC Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Univar Solutions Inc (UNVR):企業の財務・戦略的SWOT分析
    Univar Solutions Inc (UNVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • CITIC Telecom International Holdings Ltd (1883):企業の財務・戦略的SWOT分析
    CITIC Telecom International Holdings Ltd (1883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Puma Energy Holdings Pte Ltd:企業の戦略的SWOT分析
    Puma Energy Holdings Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Syndax Pharmaceuticals Inc (SNDX):企業の財務・戦略的SWOT分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the tre …
  • Matisa Materiel Industriel S.A.:企業の戦略・SWOT・財務分析
    Matisa Materiel Industriel S.A. - Strategy, SWOT and Corporate Finance Report Summary Matisa Materiel Industriel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Indian Bank:戦略・SWOT・企業財務分析
    Indian Bank - Strategy, SWOT and Corporate Finance Report Summary Indian Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • iBio Inc (IBIO):企業の財務・戦略的SWOT分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • ContourGlobal plc (GLO):電力:M&Aディール及び事業提携情報
    Summary ContourGlobal plc (ContourGlobal) formerly ContourGlobal Ltd, is an energy company. It develops, acquires, owns, and operates wholesale power generation assets under long-term contracts. The company creates asset by taking them through the permitting, financing, and construction processes, a …
  • Catalyst Pharmaceuticals Inc (CPRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company that develops prescription drugs targeting rare neurological and neuromuscular diseases. The company focuses on specific conditions such as infantile spasms, complex partial seizures, Lambert-Eaton myasthenic syndrome (LE …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆